Editas Medicine cleared for first human gene-editing trial
Australian authorities cleared Editas Medicine’s experimental gene-editing treatment for its first human clinical trial, with EDIT shares up about 4.7% before paring gains.
Australian authorities cleared Editas Medicine’s experimental gene-editing treatment for its first human clinical trial, with EDIT shares up about 4.7% before paring gains.